Early-onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer

Clinical Colorectal Cancer

Volumn 16, Issue 4, 2017, Pages 293-299.e6

  Yeo, Heather ^a,b   Betel, Doron ^a   Abelson, Jonathan S ^a   Zheng, Xi E ^b   Yantiss, Rhonda ^a   Shah, Manish A ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Behavioral Risk Factor Surveillance System; Colorectal neoplasms; Epidemiology; Risk factors; SEER program

Indexed keywords

ADULT; ARTICLE; ASCENDING COLON; BLACK PERSON; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; COLLOID CARCINOMA; COLORECTAL CANCER; DEMOGRAPHY; EARLY CANCER; EARLY ONSET COLORECTAL CANCER; FAMILY HISTORY; FEMALE; GEOGRAPHIC DISTRIBUTION; HISPANIC; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RECTUM; RISK FACTOR; SIGNET RING CARCINOMA; TRADITIONAL COLORECTAL CANCER; UNITED STATES; AGE; CANCER GRADING; COLORECTAL TUMOR; GENETICS; INCIDENCE; MIDDLE AGED; MUTATION; ONSET AGE; PATHOLOGY; YOUNG ADULT;

ADENOCARCINOMA, MUCINOUS; ADULT; AGE FACTORS; AGE OF ONSET; CARCINOMA, SIGNET RING CELL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; RISK FACTORS; SEER PROGRAM; YOUNG ADULT;

EID: 85031112583     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2017.06.002     Document Type: Article

References (36)

1. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J Clin 66 (2016), 7–30.
2. Dozois, E.J., Boardman, L.A., Suwanthanma, W., et al. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome?. Medicine (Baltimore) 87 (2008), 259–263.
3. Siegel, R.L., Jemal, A., Ward, E.M., Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 18 (2009), 1695–1698.
4. You, Y.N., Xing, Y., Feig, B.W., Chang, G.J., Cormier, J.N., Young-onset colorectal cancer: is it time to pay attention?. Arch Intern Med 172 (2012), 287–289.
5. Ahnen, D.J., Wade, S.W., Jones, W.F., et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 89 (2014), 216–224.
6. Austin, H., Henley, S.J., King, J., Richardson, L.C., Eheman, C., Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening. Cancer Causes Control 25 (2014), 191–201.
7. Davis, D.M., Marcet, J.E., Frattini, J.C., Prather, A.D., Mateka, J.J., Nfonsam, V.N., Is it time to lower the recommended screening age for colorectal cancer?. J Am Coll Surg 213 (2011), 352–361.
8. O'Connell, J.B., Maggard, M.A., Liu, J.H., Etzioni, D.A., Livingston, E.H., Ko, C.Y., Rates of colon and rectal cancers are increasing in young adults. Am Surg 69 (2003), 866–872.
9. Chang, D.T., Pai, R.K., Rybicki, L.A., et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol 25 (2012), 1128–1139.
10. Rahman, R., Schmaltz, C., Jackson, C.S., Simoes, E.J., Jackson-Thompson, J., Ibdah, J.A., Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer Med 4 (2015), 1863–1870.
11. Losi, L., Di Gregorio, C., Pedroni, M., et al. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. Am J Gastroenterol 100 (2005), 2280–2287.
12. Pucciarelli, S., Agostini, M., Viel, A., et al. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 46 (2003), 305–312.
13. Yantiss, R.K., Goodarzi, M., Zhou, X.K., et al. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 33 (2009), 572–582.
14. Bailey, C.E., Hu, C.Y., You, Y.N., et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 150 (2015), 17–22.
15. Fairley, T.L., Cardinez, C.J., Martin, J., et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer 107:5 Suppl (2006), 1153–1161.
16. Muzny, D.M., Bainbridge, M.N., Chang, K., et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487 (2012), 330–337.
17. Rozen, P., Liphshitz, I., Barchana, M., The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods. Eur J Cancer Prev 20 (2011), 46–53.
18. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2012 Sub (1973-2010 varying) - Linked To County Attributes -Total U.S., 1969-2011 Counties, 2013. Accessed: February 24, 2014.
19. County Health Rankings and Roadmaps. University of Wisconsin Population Health Institute, 2016 update. Available at: http://www.countyhealthrankings.org Accessed: August 15, 2015.
20. Nelson, D.E., Holtzman, D., Bolen, J., Stanwyck, C.A., Mack, K.A., Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soz Praventivmed 46:Suppl 1 (2001), S3–S42.
21. The Cancer Genome Atlas. National Institute of Health; National Cancer Institute; National Human Genome Research Institute, 2015 update. Available at: https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp Accessed: October 15, 2014.
22. Kennedy, S.R., Loeb, L.A., Herr, A.J., Somatic mutations in aging, cancer and neurodegeneration. Mech Ageing Dev 133 (2012), 118–126.
23. Dong, M., Guda, K., Nambiar, P.R., et al. Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis 24 (2003), 307–315.
24. Schumacher, Y., Aparicio, T., Ourabah, S., et al. Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth. Oncogene 35 (2015), 2602–2614.
25. Parsons, D.W., Wang, T.L., Samuels, Y., et al. Colorectal cancer: mutations in a signalling pathway. Nature, 436, 2005, 792.
26. Vogelstein, B., Kinzler, K.W., Cancer genes and the pathways they control. Nat Med 10 (2004), 789–799.
27. Carvalho, B., Sillars-Hardebol, A.H., Postma, C., et al. Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism. Cell Oncol (Dordr) 35 (2012), 53–63.
28. Zahir, M.N., Azhar, E.M., Rafiq, S., Ghias, K., Shabbir-Moosajee, M., Clinical features and outcome of sporadic colorectal carcinoma in young patients: a cross-sectional analysis from a developing country. ISRN Oncol, 2014, 2014, 461570.
29. Meyer, J.E., Narang, T., Schnoll-Sussman, F.H., Pochapin, M.B., Christos, P.J., Sherr, D.L., Increasing incidence of rectal cancer in patients aged younger than 40 years. Cancer 116 (2010), 4354–4359.
30. Hofstad, B., Vatn, M., Growth rate of colon polyps and cancer. Gastrointest Endosc Clin N Am 7 (1997), 345–363.
31. Winawer, S., Fletcher, R., Rex, D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124 (2003), 544–560.
32. Ladabaum, U., Mannalithara, A., Myer, P.A., Singh, G., Obesity, abdominal obesity, physical activity, and caloric intake in US adults: 1988 to 2010. Am J Med 127 (2014), 717–727.e712.
33. Muzny, D.M., Bainbridge, M.N., Chang, K., et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487 (2012), 330–337.
34. FireBrowse. Broad Institute of MIT & Harvard, 1/2016 update. Available at: http://firebrowse.org/?cohort=COADREAD Accessed: March 15, 2015.
35. Lawrence, M.S., Stojanov, P., Polak, P., et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499 (2013), 214–218.
36. Mermel, C.H., Schumacher, S.E., Hill, B., Meyerson, M.L., Beroukhim, R., Getz, G., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol, 12, 2011, R41.